VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q41584388 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010838.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q41584388‏
024 ‎‡a 0000-0002-4896-5982‏ ‎‡2 orcid‏
024 ‎‡a 7202390422‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q41584388‏
100 0 ‎‡a Manuel R. Teixeira‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Manuel R. Teixeira‏ ‎‡c Portuguese researcher‏ ‎‡9 en‏
400 0 ‎‡a マヌエル・R・テイシェイラ‏ ‎‡c Nghiên cứu giả ‏ ‎‡9 ja‏
400 0 ‎‡a Manuel R. Teixeira‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Manuel R. Teixeira‏ ‎‡c portugalski naukowiec‏ ‎‡9 pl‏
670 ‎‡a Author's 12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma.‏
670 ‎‡a Author's 8q Gain Is an Independent Predictor of Poor Survival in Diagnostic Needle Biopsies from Prostate Cancer Suspects‏
670 ‎‡a Author's 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas‏
670 ‎‡a Author's A genetic risk score to guide age-specific, personalized prostate cancer screening‏
670 ‎‡a Author's A genetic risk score to personalize prostate cancer screening, applied to population data‏
670 ‎‡a Author's A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer‏
670 ‎‡a Author's A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer‏
670 ‎‡a Author's A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease‏
670 ‎‡a Author's A network analysis to identify mediators of germline-driven differences in breast cancer prognosis‏
670 ‎‡a Author's A novel exonic rearrangement affecting MLH1 and the contiguous LRRFIP2 is a founder mutation in Portuguese Lynch syndrome families‏
670 ‎‡a Author's A novel MLL-SEPT2 fusion variant in therapy-related myelodysplastic syndrome‏
670 ‎‡a Author's A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia.‏
670 ‎‡a Author's A quantitative promoter methylation profile of prostate cancer.‏
670 ‎‡a Author's A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk‏
670 ‎‡a Author's A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis‏
670 ‎‡a Author's AA9int: SNP interaction pattern search using non-hierarchical additive model set‏
670 ‎‡a Author's Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer‏
670 ‎‡a Author's Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene‏
670 ‎‡a Author's Acute myeloid leukemia with inv(8)(p11q13).‏
670 ‎‡a Author's ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.‏
670 ‎‡a Author's Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes‏
670 ‎‡a Author's After Angelina and the Supreme Court Decision, where do we go from here? BRCA gene testing in Rhode Island's Portuguese population.‏
670 ‎‡a Author's Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study‏
670 ‎‡a Author's Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation‏
670 ‎‡a Author's Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations‏
670 ‎‡a Author's An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers‏
670 ‎‡a Author's Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas‏
670 ‎‡a Author's Are some breast carcinomas polyclonal in origin?‏
670 ‎‡a Author's Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma.‏
670 ‎‡a Author's Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers‏
670 ‎‡a Author's Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels‏
670 ‎‡a Author's Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis‏
670 ‎‡a Author's Assessment of fusion gene status in sarcomas using a custom made fusion gene microarray‏
670 ‎‡a Author's Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci‏
670 ‎‡a Author's Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.‏
670 ‎‡a Author's Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients‏
670 ‎‡a Author's Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness‏
670 ‎‡a Author's Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer‏
670 ‎‡a Author's Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer‏
670 ‎‡a Author's Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers‏
670 ‎‡a Author's Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation‏
670 ‎‡a Author's Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci‏
670 ‎‡a Author's Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry‏
670 ‎‡a Author's Blood lipids and prostate cancer: a Mendelian randomization analysis‏
670 ‎‡a Author's BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populations‏
670 ‎‡a Author's Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia‏
670 ‎‡a Author's BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families‏
670 ‎‡a Author's BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.‏
670 ‎‡a Author's BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers‏
670 ‎‡a Author's Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores‏
670 ‎‡a Author's Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.‏
670 ‎‡a Author's Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.‏
670 ‎‡a Author's Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers‏
670 ‎‡a Author's Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case‏
670 ‎‡a Author's Carcinoma of the thyroid with Ewing/PNET family tumor elements: a tumor of unknown histogenesis‏
670 ‎‡a Author's Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis‏
670 ‎‡a Author's Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH‏
670 ‎‡a Author's Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue‏
670 ‎‡a Author's Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors.‏
670 ‎‡a Author's Chromosome analysis and molecular cytogenetic investigations of an epithelioid hemangioendothelioma‏
670 ‎‡a Author's Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors‏
670 ‎‡a Author's Chromosome Mechanisms Giving Rise to the TMPRSS2-ERG Fusion Oncogene in Prostate Cancer and HGPIN Lesions‏
670 ‎‡a Author's Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study‏
670 ‎‡a Author's Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patients‏
670 ‎‡a Author's Co-occurrence of nonsense mutations in MSH6 and MSH2 in Lynch syndrome families evidencing that not all truncating mutations are equal‏
670 ‎‡a Author's Coexistence of alternative MLL–SEPT9 fusion transcripts in an acute myeloid leukemia with t‏
670 ‎‡a Author's Coexistence of alternative MLL–SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25)‏
670 ‎‡a Author's Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin‏
670 ‎‡a Author's Combined classical and molecular cytogenetic analysis of cancer.‏
670 ‎‡a Author's Combined RxFISH/G-banding allows refined karyotyping of solid tumors‏
670 ‎‡a Author's Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing‏
670 ‎‡a Author's Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas‏
670 ‎‡a Author's Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer‏
670 ‎‡a Author's Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosome-specific painting‏
670 ‎‡a Author's Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia‏
670 ‎‡a Author's Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation‏
670 ‎‡a Author's Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples‏
670 ‎‡a Author's Correspondence: SEMA4A variation and risk of colorectal cancer‏
670 ‎‡a Author's Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma‏
670 ‎‡a Author's CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas‏
670 ‎‡a Author's Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.‏
670 ‎‡a Author's Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene‏
670 ‎‡a Author's Cytogenetic abnormalities in anin situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer‏
670 ‎‡a Author's Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci.‏
670 ‎‡a Author's Cytogenetic analysis of several pseudomyxoma peritonei lesions originating from a mucinous cystadenoma of the appendix‏
670 ‎‡a Author's Cytogenetic analysis of tumor clonality‏
670 ‎‡a Author's Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t‏
670 ‎‡a Author's Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17)‏
670 ‎‡a Author's Cytogenetic characterization of tumors of the vulva and vagina‏
670 ‎‡a Author's Cytogenetic clues to breast carcinogenesis‏
670 ‎‡a Author's Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients‏
670 ‎‡a Author's Cytogenetic polyclonality in tumors of the breast.‏
670 ‎‡a Author's Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis‏
670 ‎‡a Author's Desmoplastic small round cell tumor: diagnosis by fine-needle aspiration cytology‏
670 ‎‡a Author's Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer‏
670 ‎‡a Author's Detailed genome-wide screening for inter- and intrachromosomal abnormalities by sequential G-banding and RxFISH color banding of the same metaphase cells‏
670 ‎‡a Author's Detection of gene promoter hypermethylation in fine needle washings from breast lesions.‏
670 ‎‡a Author's Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution‏
670 ‎‡a Author's Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions‏
670 ‎‡a Author's Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci‏
670 ‎‡a Author's Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status‏
670 ‎‡a Author's DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers‏
670 ‎‡a Author's DNA repair genes are selectively mutated in diffuse large B cell lymphomas‏
670 ‎‡a Author's EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study‏
670 ‎‡a Author's Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours‏
670 ‎‡a Author's Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.‏
670 ‎‡a Author's Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential‏
670 ‎‡a Author's Epigenetic regulation of Wnt signaling pathway in urological cancer‏
670 ‎‡a Author's Evaluation of breast cancer polyclonality by combined chromosome banding and comparative genomic hybridization analysis‏
670 ‎‡a Author's Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers‏
670 ‎‡a Author's Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.‏
670 ‎‡a Author's Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changes‏
670 ‎‡a Author's Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.‏
670 ‎‡a Author's Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour‏
670 ‎‡a Author's Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies‏
670 ‎‡a Author's Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression‏
670 ‎‡a Author's Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes‏
670 ‎‡a Author's Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes‏
670 ‎‡a Author's Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.‏
670 ‎‡a Author's Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk‏
670 ‎‡a Author's Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer‏
670 ‎‡a Author's Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers‏
670 ‎‡a Author's FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer‏
670 ‎‡a Author's Fluorescence in situ hybridization of old G-banded and mounted chromosome preparations‏
670 ‎‡a Author's FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility‏
670 ‎‡a Author's Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia‏
670 ‎‡a Author's Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions‏
670 ‎‡a Author's Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas‏
670 ‎‡a Author's Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes‏
670 ‎‡a Author's Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.‏
670 ‎‡a Author's Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus‏
670 ‎‡a Author's Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis‏
670 ‎‡a Author's Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array‏
670 ‎‡a Author's Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond BRCA1/BRCA2‏
670 ‎‡a Author's Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.‏
670 ‎‡a Author's Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas‏
670 ‎‡a Author's Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations‏
670 ‎‡a Author's Genetic diagnosis of alveolar rhabdomyosarcoma in the bone marrow of a patient without evidence of primary tumor‏
670 ‎‡a Author's Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis.‏
670 ‎‡a Author's Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) C‏
670 ‎‡a Author's Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients‏
670 ‎‡a Author's Genome profiling of breast cancer cells selected against in vitro shows copy number changes‏
670 ‎‡a Author's Genome signatures of colon carcinoma cell lines‏
670 ‎‡a Author's Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer‏
670 ‎‡a Author's Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses‏
670 ‎‡a Author's Genome-wide association study of germline variants and breast cancer-specific mortality‏
670 ‎‡a Author's Genome-wide association study of prostate cancer-specific survival‏
670 ‎‡a Author's Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types‏
670 ‎‡a Author's Genomic aberrations in carcinomas of the uterine corpus‏
670 ‎‡a Author's Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making‏
670 ‎‡a Author's Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group‏
670 ‎‡a Author's Genomic characterization of two large Alu-mediated rearrangements of the BRCA1 gene‏
670 ‎‡a Author's Genotypic and phenotypic classification of cancer: How should the impact of the two diagnostic approaches best be balanced?‏
670 ‎‡a Author's Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer‏
670 ‎‡a Author's Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.‏
670 ‎‡a Author's Germline variation at 8q24 and prostate cancer risk in men of European ancestry‏
670 ‎‡a Author's Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin‏
670 ‎‡a Author's Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study‏
670 ‎‡a Author's Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways‏
670 ‎‡a Author's Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications‏
670 ‎‡a Author's Heterogeneous genetic profiles in soft tissue myoepitheliomas‏
670 ‎‡a Author's High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.‏
670 ‎‡a Author's High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer‏
670 ‎‡a Author's Highly sensitive detection of the MGB1 transcript‏
670 ‎‡a Author's Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients‏
670 ‎‡a Author's Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case‏
670 ‎‡a Author's Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results.‏
670 ‎‡a Author's Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer‏
670 ‎‡a Author's Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer‏
670 ‎‡a Author's Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array‏
670 ‎‡a Author's Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer‏
670 ‎‡a Author's Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus‏
670 ‎‡a Author's Identification of previously unrecognized FAP in children with Gardner fibroma‏
670 ‎‡a Author's Identification of six new susceptibility loci for invasive epithelial ovarian cancer‏
670 ‎‡a Author's Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas‏
670 ‎‡a Author's Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer‏
670 ‎‡a Author's Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients‏
670 ‎‡a Author's Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome‏
670 ‎‡a Author's Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity‏
670 ‎‡a Author's Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women‏
670 ‎‡a Author's Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers‏
670 ‎‡a Author's International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.‏
670 ‎‡a Author's Intraepidermal epidermotropic metastatic melanoma: a clinical and histopathological mimicker of melanoma in situ occurring in multiplicity‏
670 ‎‡a Author's Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases‏
670 ‎‡a Author's Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis‏
670 ‎‡a Author's Karyotypic changes in phyllodes tumors of the breast‏
670 ‎‡a Author's Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer‏
670 ‎‡a Author's Karyotypic divergence and convergence in two synchronous lung metastases of a clear cell sarcoma of tendons and aponeuroses with t‏
670 ‎‡a Author's Karyotypic divergence and convergence in two synchronous lung metastases of a clear cell sarcoma of tendons and aponeuroses with t(12;22)(q13;q12) and type 1 EWS/ATF1.‏
670 ‎‡a Author's Karyotypic Evolution in Breast Carcinomas with i‏
670 ‎‡a Author's Karyotypic Evolution in Breast Carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the Primary Chromosome Abnormality‏
670 ‎‡a Author's Karyotypic Findings in Tumors of the Vulva and Vagina‏
670 ‎‡a Author's Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trial‏
670 ‎‡a Author's Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion‏
670 ‎‡a Author's Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.‏
670 ‎‡a Author's Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers‏
670 ‎‡a Author's Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.‏
670 ‎‡a Author's Mitochondrial DNA-control region sequence variation in the NE Portuguese Jewish community‏
670 ‎‡a Author's Mitochondrial genome alterations in rectal and sigmoid carcinomas‏
670 ‎‡a Author's MLL-SEPTIN gene fusions in hematological malignancies‏
670 ‎‡a Author's Molecular characterization of a rare MLL–AF4‏
670 ‎‡a Author's Molecular characterization of a rare MLL–AF4 (MLL–AFF1) fusion rearrangement in infant leukemia‏
670 ‎‡a Author's Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions‏
670 ‎‡a Author's Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.‏
670 ‎‡a Author's Molecular cytogenetic characterization of proximal-type epithelioid sarcoma‏
670 ‎‡a Author's Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.‏
670 ‎‡a Author's Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements‏
670 ‎‡a Author's MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease‏
670 ‎‡a Author's MT1G hypermethylation is associated with higher tumor stage in prostate cancer‏
670 ‎‡a Author's Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma.‏
670 ‎‡a Author's Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans‏
670 ‎‡a Author's Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences?‏
670 ‎‡a Author's Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations‏
670 ‎‡a Author's Mutations in exon 14 of dihydropyrimidine dehydrogenase and 5-Fluorouracil toxicity in Portuguese colorectal cancer patients‏
670 ‎‡a Author's Myeloid Disease with the CSF3R T618I Mutation after CLL‏
670 ‎‡a Author's NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.‏
670 ‎‡a Author's Negative MR4·0 chronic myeloid leukaemia and its possible implications for treatment-free remission‏
670 ‎‡a Author's No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.‏
670 ‎‡a Author's No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin‏
670 ‎‡a Author's Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer‏
670 ‎‡a Author's Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis.‏
670 ‎‡a Author's Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?‏
670 ‎‡a Author's Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas.‏
670 ‎‡a Author's PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS‏
670 ‎‡a Author's Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families‏
670 ‎‡a Author's Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.‏
670 ‎‡a Author's Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression‏
670 ‎‡a Author's PNET with neuroendocrine differentiation of the lung: Report of an unusual entity.‏
670 ‎‡a Author's POLE somatic mutations in advanced colorectal cancer‏
670 ‎‡a Author's Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts‏
670 ‎‡a Author's Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium‏
670 ‎‡a Author's Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report‏
670 ‎‡a Author's Portuguese c.156_157insAlu BRCA2 founder mutation: gastrointestinal and tongue neoplasias may be part of the phenotype.‏
670 ‎‡a Author's Potential clinical applications of circulating cell-free DNA in ovarian cancer patients‏
670 ‎‡a Author's Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.‏
670 ‎‡a Author's POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15).‏
670 ‎‡a Author's Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores‏
670 ‎‡a Author's Prediction of individual genetic risk to prostate cancer using a polygenic score‏
670 ‎‡a Author's Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients‏
670 ‎‡a Author's Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status‏
670 ‎‡a Author's Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.‏
670 ‎‡a Author's Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort‏
670 ‎‡a Author's Publisher Correction: Shared heritability and functional enrichment across six solid cancers‏
670 ‎‡a Author's Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions‏
670 ‎‡a Author's Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors‏
670 ‎‡a Author's Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker‏
670 ‎‡a Author's Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis‏
670 ‎‡a Author's Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer‏
670 ‎‡a Author's Relative 8q gain predicts disease-specific survival irrespective of the TMPRSS2-ERG fusion status in diagnostic biopsies of prostate cancer.‏
670 ‎‡a Author's Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients‏
670 ‎‡a Author's Reply to AnnaMaria Cianciulli, Roberta Merola and Costantino Leonardo’s Letter to the Editor re: Franclim R. Ribeiro, Rui Henrique, Ana T. Martins, Carmen Jerónimo and Manuel R. Teixeira. Relative Copy Number Gain of MYC in Diagnostic Needle Biops‏
670 ‎‡a Author's Screening and characterization of BRCA2 c.156_157insAlu in Brazil: Results from 1380 individuals from the South and Southeast‏
670 ‎‡a Author's SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t‏
670 ‎‡a Author's SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23).‏
670 ‎‡a Author's Shared heritability and functional enrichment across six solid cancers‏
670 ‎‡a Author's SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas‏
670 ‎‡a Author's SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns‏
670 ‎‡a Author's Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts‏
670 ‎‡a Author's Statistical dissection of genetic pathways involved in prostate carcinogenesis‏
670 ‎‡a Author's Structural and expression changes of septins in myeloid neoplasia‏
670 ‎‡a Author's Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation‏
670 ‎‡a Author's Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.‏
670 ‎‡a Author's Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study‏
670 ‎‡a Author's TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers‏
670 ‎‡a Author's Telomerase activity and genetic alterations in primary breast carcinomas‏
670 ‎‡a Author's The Brazilian Founder MutationTP53p.R337H is Uncommon in Portuguese Women Diagnosed with Breast Cancer‏
670 ‎‡a Author's The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal.‏
670 ‎‡a Author's The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor‏
670 ‎‡a Author's The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium‏
670 ‎‡a Author's The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer‏
670 ‎‡a Author's The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation‏
670 ‎‡a Author's The MLL recombinome of acute leukemias in 2013.‏
670 ‎‡a Author's The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families‏
670 ‎‡a Author's The nonsense mutation MSH2 c.2152C>T shows a founder effect in Portuguese Lynch syndrome families‏
670 ‎‡a Author's The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes‏
670 ‎‡a Author's The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer‏
670 ‎‡a Author's The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry‏
670 ‎‡a Author's The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer‏
670 ‎‡a Author's The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases‏
670 ‎‡a Author's Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples‏
670 ‎‡a Author's TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions‏
670 ‎‡a Author's TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset‏
670 ‎‡a Author's TP53mutations are associated with a particular pattern of genomic imbalances in breast carcinomas‏
670 ‎‡a Author's Transcriptome instability as a molecular pan-cancer characteristic of carcinomas‏
670 ‎‡a Author's Transcriptome-wide association study of breast cancer risk by estrogen-receptor status‏
670 ‎‡a Author's Translocation (3;3)(p14;q29) as the Primary Chromosome Abnormality in a Peritoneal Mesothelioma‏
670 ‎‡a Author's Truncating and missense PPM1D mutations in early-onset and/or familial/hereditary prostate cancer patients.‏
670 ‎‡a Author's Tumors of the Breast‏
670 ‎‡a Author's Tumors of the Male Genital Organs‏
670 ‎‡a Author's Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements.‏
670 ‎‡a Author's Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes‏
670 ‎‡a Author's Variability of the paracrine-induced osteoclastogenesis by human breast cancer cell lines.‏
670 ‎‡a Author's Widening the spectrum of Lynch syndrome: first report of testicular seminoma attributable to MSH2 loss‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/viaf/98957008‏
909 ‎‡a (orcid) 0000000248965982‏ ‎‡9 1‏
909 ‎‡a (scopus) 7202390422‏ ‎‡9 1‏
912 ‎‡a transcriptomewideassociationstudyofbreastcancerriskbyestrogenreceptorstatus‏ ‎‡A Transcriptome-wide association study of breast cancer risk by estrogen-receptor status‏ ‎‡9 1‏
912 ‎‡a fancmparg658truncatingvariantisassociatedwithriskoftriplenegativebreastcancer‏ ‎‡A The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer‏ ‎‡9 1‏
912 ‎‡a targetedprostatecancerscreeninginbrca1andbrca2mutationcarriersresultsfromtheinitialscreeningroundoftheimpactstudy‏ ‎‡A Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study‏ ‎‡9 1‏
912 ‎‡a sharedheritabilityandfunctionalenrichmentacross6solidcancers‏ ‎‡A Shared heritability and functional enrichment across six solid cancers‏ ‎‡9 1‏
912 ‎‡a publishercorrectionsharedheritabilityandfunctionalenrichmentacross6solidcancers‏ ‎‡A Publisher Correction: Shared heritability and functional enrichment across six solid cancers‏ ‎‡9 1‏
912 ‎‡a prostatespecificantigenvelocityinaprospectiveprostatecancerscreeningstudyofmenwithgeneticpredisposition‏ ‎‡A Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.‏ ‎‡9 1‏
912 ‎‡a predictionofindividualgeneticrisktoprostatecancerusingapolygenicscore‏ ‎‡A Prediction of individual genetic risk to prostate cancer using a polygenic score‏ ‎‡9 1‏
912 ‎‡a predictionofbreastandprostatecancerrisksinmalebrca1andbrca2mutationcarriersusingpolygenicriskscores‏ ‎‡A Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores‏ ‎‡9 1‏
912 ‎‡a polygenichazardscoretoguidescreeningforaggressiveprostatecancerdevelopmentandvalidationinlargescalecohorts‏ ‎‡A Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts‏ ‎‡9 1‏
912 ‎‡a palb2chek2andatmrarevariantsandcancerriskdatafromcogs‏ ‎‡A PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS‏ ‎‡9 1‏
912 ‎‡a noclinicalutilityofkrasvariantrs61764370forovarianorbreastcancer‏ ‎‡A No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.‏ ‎‡9 1‏
912 ‎‡a mutationalspectruminaworldwidestudyof29700familieswithbrca1orbrca2mutations‏ ‎‡A Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations‏ ‎‡9 1‏
912 ‎‡a multiplenovelprostatecancersusceptibilitysignalsidentifiedbyfinemappingofknownrisklociamongeuropeans‏ ‎‡A Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans‏ ‎‡9 1‏
912 ‎‡a metaanalysisofgenomewideassociationstudiesidentifiescommonsusceptibilitypolymorphismsforcolorectalandendometrialcancernearsh2b3andtshz1‏ ‎‡A Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.‏ ‎‡9 1‏
912 ‎‡a mendelianrandomisationstudyofheightandbodymassindexasmodifiersofovariancancerriskin22588brca1andbrca2mutationcarriers‏ ‎‡A Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers‏ ‎‡9 1‏
912 ‎‡a malebreastcancerinbrca1andbrca2mutationcarrierspathologydatafromtheconsortiumofinvestigatorsofmodifiersofbrca12‏ ‎‡A Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.‏ ‎‡9 1‏
912 ‎‡a interimresultsfromtheimpactstudyevidenceforprostatespecificantigenscreeninginbrca2mutationcarriers‏ ‎‡A Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers‏ ‎‡9 1‏
912 ‎‡a inheritanceofdeleteriousmutationsatbothbrca1andbrca2inaninternationalsampleof32295women‏ ‎‡A Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women‏ ‎‡9 1‏
912 ‎‡a identificationof10variantsassociatedwithriskofestrogenreceptornegativebreastcancer‏ ‎‡A Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer‏ ‎‡9 1‏
912 ‎‡a identificationof6newsusceptibilitylociforinvasiveepithelialovariancancer‏ ‎‡A Identification of six new susceptibility loci for invasive epithelial ovarian cancer‏ ‎‡9 1‏
912 ‎‡a identificationofindependentassociationsignalsandputativefunctionalvariantsforbreastcancerriskthroughfinescalemappingofthe12p11locus‏ ‎‡A Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus‏ ‎‡9 1‏
912 ‎‡a identificationof4novelsusceptibilitylociforoestrogenreceptornegativebreastcancer‏ ‎‡A Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer‏ ‎‡9 1‏
912 ‎‡a identificationof23newprostatecancersusceptibilitylociusingtheicogscustomgenotypingarray‏ ‎‡A Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array‏ ‎‡9 1‏
912 ‎‡a identificationof12newsusceptibilitylocifordifferenthistotypesofepithelialovariancancer‏ ‎‡A Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer‏ ‎‡9 1‏
912 ‎‡a heightandbodymassindexasmodifiersofbreastcancerriskinbrca12mutationcarriersamendelianrandomizationstudy‏ ‎‡A Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study‏ ‎‡9 1‏
912 ‎‡a germlinevariationat8q24andprostatecancerriskinmenofeuropeanancestry‏ ‎‡A Germline variation at 8q24 and prostate cancer risk in men of European ancestry‏ ‎‡9 1‏
912 ‎‡a genomewidemetaanalysesofbreastovarianandprostatecancerassociationstudiesidentifymultiplenewsusceptibilitylocisharedbyatleast2cancertypes‏ ‎‡A Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types‏ ‎‡9 1‏
912 ‎‡a genomewideassociationstudyofprostatecancerspecificsurvival‏ ‎‡A Genome-wide association study of prostate cancer-specific survival‏ ‎‡9 1‏
912 ‎‡a genomewideassociationstudyofgermlinevariantsandbreastcancerspecificmortality‏ ‎‡A Genome-wide association study of germline variants and breast cancer-specific mortality‏ ‎‡9 1‏
912 ‎‡a genomewideassociationstudyidentifies32novelbreastcancersusceptibilitylocifromoverallandsubtypespecificanalyses‏ ‎‡A Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses‏ ‎‡9 1‏
912 ‎‡a genomewideassociationandtranscriptomestudiesidentifytargetgenesandrisklociforbreastcancer‏ ‎‡A Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer‏ ‎‡9 1‏
912 ‎‡a functionalmechanismsunderlyingpleiotropicriskallelesatthe19p131breastovariancancersusceptibilitylocus‏ ‎‡A Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus‏ ‎‡9 1‏
912 ‎‡a finescalemappingat9p222identifiescandidatecausalvariantsthatmodifyovariancancerriskinbrca1andbrca2mutationcarriers‏ ‎‡A Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers‏ ‎‡9 1‏
912 ‎‡a finemappingthehoxbregiondetectscommonvariantstaggingararecodingalleleevidenceforsyntheticassociationinprostatecancer‏ ‎‡A Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer‏ ‎‡9 1‏
912 ‎‡a finemappingofthehnf1bmulticancerlocusidentifiescandidatevariantsthatmediateendometrialcancerrisk‏ ‎‡A Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk‏ ‎‡9 1‏
912 ‎‡a finemappingofprostatecancersusceptibilitylociinalargemetaanalysisidentifiescandidatecausalvariants‏ ‎‡A Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.‏ ‎‡9 1‏
912 ‎‡a finemappingof150breastcancerriskregionsidentifies191likelytargetgenes‏ ‎‡A Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes‏ ‎‡9 1‏
912 ‎‡a finemappingof150breastcancerriskregionsidentifies178highconfidencetargetgenes‏ ‎‡A Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes‏ ‎‡9 1‏
912 ‎‡a finemappingidentifiesmultipleprostatecancerrisklociat5p151ofwhichassociateswithtertexpression‏ ‎‡A Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression‏ ‎‡9 1‏
912 ‎‡a evaluationofpolygenicriskscoresforbreastandovariancancerriskpredictioninbrca1andbrca2mutationcarriers‏ ‎‡A Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers‏ ‎‡9 1‏
912 ‎‡a dnaglycosylasesinvolvedinbaseexcisionrepairmaybeassociatedwithcancerriskinbrca1andbrca2mutationcarriers‏ ‎‡A DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers‏ ‎‡9 1‏
912 ‎‡a geneticriskscoretoguideagespecificpersonalizedprostatecancerscreening‏ ‎‡A A genetic risk score to guide age-specific, personalized prostate cancer screening‏ ‎‡9 1‏
912 ‎‡a geneticriskscoretopersonalizeprostatecancerscreeningappliedtopopulationdata‏ ‎‡A A genetic risk score to personalize prostate cancer screening, applied to population data‏ ‎‡9 1‏
912 ‎‡a metaanalysisof87040individualsidentifies23newsusceptibilitylociforprostatecancer‏ ‎‡A A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer‏ ‎‡9 1‏
912 ‎‡a metaanalysisofgenomewideassociationstudiestoidentifyprostatecancersusceptibilitylociassociatedwithaggressiveandnonaggressivedisease‏ ‎‡A A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease‏ ‎‡9 1‏
912 ‎‡a networkanalysistoidentifymediatorsofgermlinedrivendifferencesinbreastcancerprognosis‏ ‎‡A A network analysis to identify mediators of germline-driven differences in breast cancer prognosis‏ ‎‡9 1‏
912 ‎‡a transcriptomewideassociationstudyamong97898womentoidentifycandidatesusceptibilitygenesforepithelialovariancancerrisk‏ ‎‡A A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk‏ ‎‡9 1‏
912 ‎‡a originalphylogeneticapproachidentifiedmitochondrialhaplogroupt1a1asinverselyassociatedwithbreastcancerriskinbrca2mutationcarriers‏ ‎‡A An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers‏ ‎‡9 1‏
912 ‎‡a assessingassociationsbetweentheaurkahmmrtpx2tubg1functionalmoduleandbreastcancerriskinbrca12mutationcarriers‏ ‎‡A Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers‏ ‎‡9 1‏
919 ‎‡a carcinomaofthethyroidwithewingpnetfamilytumorelementsatumorofunknownhistogenesis‏ ‎‡A Carcinoma of the thyroid with Ewing/PNET family tumor elements: a tumor of unknown histogenesis‏ ‎‡9 1‏
919 ‎‡a carcinomaofthethyroidwithewingfamilytumorelementsandfavorableprognosisreportofa2case‏ ‎‡A Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case‏ ‎‡9 1‏
919 ‎‡a wideningthespectrumoflynchsyndrome1reportoftesticularseminomaattributabletomsh2loss‏ ‎‡A Widening the spectrum of Lynch syndrome: first report of testicular seminoma attributable to MSH2 loss‏ ‎‡9 1‏
919 ‎‡a variabilityoftheparacrineinducedosteoclastogenesisbyhumanbreastcancercelllines‏ ‎‡A Variability of the paracrine-induced osteoclastogenesis by human breast cancer cell lines.‏ ‎‡9 1‏
919 ‎‡a validationofanextgenerationsequencingpipelineforthemoleculardiagnosisofmultipleinheritedcancerpredisposingsyndromes‏ ‎‡A Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes‏ ‎‡9 1‏
919 ‎‡a uncoveringpotentialdownstreamtargetsofoncogenicgrproverexpressioninprostatecarcinomasharboringetsrearrangements‏ ‎‡A Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements.‏ ‎‡9 1‏
919 ‎‡a tumorsofthemalegenitalorgans‏ ‎‡A Tumors of the Male Genital Organs‏ ‎‡9 1‏
919 ‎‡a tumorsofthebreast‏ ‎‡A Tumors of the Breast‏ ‎‡9 1‏
919 ‎‡a truncatingandmissenseppm1dmutationsinearlyonsetandorfamilialhereditaryprostatecancerpatients‏ ‎‡A Truncating and missense PPM1D mutations in early-onset and/or familial/hereditary prostate cancer patients.‏ ‎‡9 1‏
919 ‎‡a translocation33p14q29astheprimarychromosomeabnormalityinaperitonealmesothelioma‏ ‎‡A Translocation (3;3)(p14;q29) as the Primary Chromosome Abnormality in a Peritoneal Mesothelioma‏ ‎‡9 1‏
919 ‎‡a transcriptomeinstabilityasamolecularpancancercharacteristicofcarcinomas‏ ‎‡A Transcriptome instability as a molecular pan-cancer characteristic of carcinomas‏ ‎‡9 1‏
919 ‎‡a tp53mutationsareassociatedwithaparticularpatternofgenomicimbalancesinbreastcarcinomas‏ ‎‡A TP53mutations are associated with a particular pattern of genomic imbalances in breast carcinomas‏ ‎‡9 1‏
919 ‎‡a tp53germlinemutationsinportugalandgeneticmodifiersofageatcanceronset‏ ‎‡A TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset‏ ‎‡9 1‏
919 ‎‡a tmprss2erggenefusioncausingergoverexpressionprecedeschromosomecopynumberchangesinprostatecarcinomasandpairedhgpinlesions‏ ‎‡A TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions‏ ‎‡9 1‏
919 ‎‡a 3epigeneticbiomarkersgdf15tmeff2andvimaccuratelypredictbladdercancerfromdnabasedanalysesofurinesamples‏ ‎‡A Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples‏ ‎‡9 1‏
919 ‎‡a spectrumoffancmproteintruncatingvariantsineuropeanbreastcancercases‏ ‎‡A The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases‏ ‎‡9 1‏
919 ‎‡a roleoftp53pathogenicvariantsinearlyonsether2positivebreastcancer‏ ‎‡A The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer‏ ‎‡9 1‏
919 ‎‡a roleoftargetedbrca1brca2mutationanalysisinhereditarybreastovariancancerfamiliesofportugueseancestry‏ ‎‡A The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry‏ ‎‡9 1‏
919 ‎‡a roleofgermlinemutationsinthebrca12andmismatchrepairgenesinmenascertainedforearlyonsetandorfamilialprostatecancer‏ ‎‡A The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer‏ ‎‡9 1‏
919 ‎‡a orderofgeneticeventsassociatedwithcolorectalcancerprogressioninferredfrommetaanalysisofcopynumberchanges‏ ‎‡A The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes‏ ‎‡9 1‏
919 ‎‡a nonsensemutationmsh21002152ctshowsafoundereffectinportugueselynchsyndromefamilies‏ ‎‡A The nonsense mutation MSH2 c.2152C>T shows a founder effect in Portuguese Lynch syndrome families‏ ‎‡9 1‏
919 ‎‡a msh2100388389delmutationshowsafoundereffectinportugueselynchsyndromefamilies‏ ‎‡A The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families‏ ‎‡9 1‏
919 ‎‡a mllrecombinomeofacuteleukemiasin‏ ‎‡A The MLL recombinome of acute leukemias in 2013.‏ ‎‡9 1‏
919 ‎‡a lossofnkx31expressionintesticularandprostatecancersisnotcausedbypromoterhypermethylation‏ ‎‡A The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation‏ ‎‡9 1‏
919 ‎‡a effectsofheightandbmionprostatecancerincidenceandmortalityamendelianrandomizationstudyin20848casesand20214controlsfromthepracticalconsortium‏ ‎‡A The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium‏ ‎‡9 1‏
919 ‎‡a chek2variant100349agisassociatedwithprostatecancerriskandcarriersshareacommonancestor‏ ‎‡A The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor‏ ‎‡9 1‏
919 ‎‡a 100156157insalubrca2rearrangementaccountsformorethan14ofdeleteriousbrcamutationsinnortherncentralportugal‏ ‎‡A The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal.‏ ‎‡9 1‏
919 ‎‡a brazilianfoundermutationtp53pr337hisuncommoninportuguesewomendiagnosedwithbreastcancer‏ ‎‡A The Brazilian Founder MutationTP53p.R337H is Uncommon in Portuguese Women Diagnosed with Breast Cancer‏ ‎‡9 1‏
919 ‎‡a telomeraseactivityandgeneticalterationsinprimarybreastcarcinomas‏ ‎‡A Telomerase activity and genetic alterations in primary breast carcinomas‏ ‎‡9 1‏
919 ‎‡a tcf21andpcdh17methylationaninnovativepanelofbiomarkersforasimultaneousdetectionofurologicalcancers‏ ‎‡A TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers‏ ‎‡9 1‏
919 ‎‡a targetednextgenerationsequencingidentifiesfunctionallydeleteriousgermlinemutationsinnovelgenesinearlyonsetfamilialprostatecancer‏ ‎‡A Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.‏ ‎‡9 1‏
919 ‎‡a targetgenemutationalpatterninlynchsyndromecolorectalcarcinomasaccordingtotumourlocationandgermlinemutation‏ ‎‡A Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation‏ ‎‡9 1‏
919 ‎‡a structuralandexpressionchangesofseptinsinmyeloidneoplasia‏ ‎‡A Structural and expression changes of septins in myeloid neoplasia‏ ‎‡9 1‏
919 ‎‡a statisticaldissectionofgeneticpathwaysinvolvedinprostatecarcinogenesis‏ ‎‡A Statistical dissection of genetic pathways involved in prostate carcinogenesis‏ ‎‡9 1‏
919 ‎‡a specificandredundantactivitiesofetv1andetv4inprostatecanceraggressivenessrevealedbycooverexpressioncellularcontexts‏ ‎‡A Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts‏ ‎‡9 1‏
919 ‎‡a snpinteractionpatternidentifiersipianintensivesearchforsnpsnpinteractionpatterns‏ ‎‡A SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns‏ ‎‡9 1‏
919 ‎‡a smarcb1ini1tumorsuppressorgeneisfrequentlyinactivatedinepithelioidsarcomas‏ ‎‡A SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas‏ ‎‡9 1‏
919 ‎‡a sept2isanewfusionpartnerofmllinacutemyeloidleukemiawitht211q37q23‏ ‎‡A SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23).‏ ‎‡9 1‏
919 ‎‡a sept2isanewfusionpartnerofmllinacutemyeloidleukemiawitht‏ ‎‡A SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t‏ ‎‡9 1‏
919 ‎‡a screeningandcharacterizationofbrca2100156157insaluinbrazilresultsfrom1380individualsfromthesouthandsoutheast‏ ‎‡A Screening and characterization of BRCA2 c.156_157insAlu in Brazil: Results from 1380 individuals from the South and Southeast‏ ‎‡9 1‏
919 ‎‡a replytoannamariacianciullirobertamerolaandcostantinoleonardoslettertotheeditorrefranclimrribeiroruihenriqueanatmartinscarmenjeronimoandmanuelrteixeirarelativecopynumbergainofmycindiagnosticneedlebiops‏ ‎‡A Reply to AnnaMaria Cianciulli, Roberta Merola and Costantino Leonardo’s Letter to the Editor re: Franclim R. Ribeiro, Rui Henrique, Ana T. Martins, Carmen Jerónimo and Manuel R. Teixeira. Relative Copy Number Gain of MYC in Diagnostic Needle Biops‏ ‎‡9 1‏
919 ‎‡a relativecopynumbergainofmycindiagnosticneedlebiopsiesisanindependentprognosticfactorforprostatecancerpatients‏ ‎‡A Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients‏ ‎‡9 1‏
919 ‎‡a relative8qgainpredictsdiseasespecificsurvivalirrespectiveofthetmprss2ergfusionstatusindiagnosticbiopsiesofprostatecancer‏ ‎‡A Relative 8q gain predicts disease-specific survival irrespective of the TMPRSS2-ERG fusion status in diagnostic biopsies of prostate cancer.‏ ‎‡9 1‏
919 ‎‡a recurrentcodingsequencevariationexplainsonlyasmallfractionofthegeneticarchitectureofcolorectalcancer‏ ‎‡A Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer‏ ‎‡9 1‏
919 ‎‡a reroleoftheoxidativednadamagerepairgeneogg1incolorectaltumorigenesis‏ ‎‡A Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis‏ ‎‡9 1‏
919 ‎‡a quantitativerarbeta2hypermethylationapromisingprostatecancermarker‏ ‎‡A Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker‏ ‎‡9 1‏
919 ‎‡a quantitativepromotermethylationanalysisofmultiplecancerrelatedgenesinrenalcelltumors‏ ‎‡A Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors‏ ‎‡9 1‏
919 ‎‡a quantitativehypermethylationofasmallpanelofgenesaugmentsthediagnosticaccuracyinfineneedleaspiratewashingsofbreastlesions‏ ‎‡A Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions‏ ‎‡9 1‏
919 ‎‡a pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort‏ ‎‡A Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort‏ ‎‡9 1‏
919 ‎‡a prostatecancerriskregionsat8q24and17q24aredifferentiallyassociatedwithsomatictmprss2ergfusionstatus‏ ‎‡A Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status‏ ‎‡9 1‏
919 ‎‡a promotermethylationandlargeintragenicrearrangementsofdpydarenotimplicatedinseveretoxicityto5fluorouracilbasedchemotherapyingastrointestinalcancerpatients‏ ‎‡A Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients‏ ‎‡9 1‏
919 ‎‡a pou1f1isanovelfusionpartnerofnup98inacutemyeloidleukemiawitht311p11p15‏ ‎‡A POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15).‏ ‎‡9 1‏
919 ‎‡a potentialdownstreamtargetgenesofaberrantetstranscriptionfactorsaredifferentiallyaffectedinewingssarcomaandprostatecarcinoma‏ ‎‡A Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.‏ ‎‡9 1‏
919 ‎‡a potentialclinicalapplicationsofcirculatingcellfreednainovariancancerpatients‏ ‎‡A Potential clinical applications of circulating cell-free DNA in ovarian cancer patients‏ ‎‡9 1‏
919 ‎‡a portuguese100156157insalubrca2foundermutationgastrointestinalandtongueneoplasiasmaybepartofthephenotype‏ ‎‡A Portuguese c.156_157insAlu BRCA2 founder mutation: gastrointestinal and tongue neoplasias may be part of the phenotype.‏ ‎‡9 1‏
919 ‎‡a ponatinibinducesasustaineddeepmolecularresponseinachronicmyeloidleukaemiapatientwithanearlyrelapsewithat315imutationfollowingallogeneichematopoieticstemcelltransplantationacasereport‏ ‎‡A Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report‏ ‎‡9 1‏
919 ‎‡a polyunsaturatedfattyacidsandprostatecancerriskamendelianrandomisationanalysisfromthepracticalconsortium‏ ‎‡A Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium‏ ‎‡9 1‏
919 ‎‡a polesomaticmutationsinadvancedcolorectalcancer‏ ‎‡A POLE somatic mutations in advanced colorectal cancer‏ ‎‡9 1‏
919 ‎‡a pnetwithneuroendocrinedifferentiationofthelungreportofanunusualentity‏ ‎‡A PNET with neuroendocrine differentiation of the lung: Report of an unusual entity.‏ ‎‡9 1‏
919 ‎‡a performanceoflynchsyndromepredictivemodelsinquantifyingthelikelihoodofgermlinemutationsinpatientswithabnormalmlh1immunoexpression‏ ‎‡A Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression‏ ‎‡9 1‏
919 ‎‡a pathologicfindingsinprophylacticandnonprophylactichysterectomyspecimensofpatientswithlynchsyndrome‏ ‎‡A Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.‏ ‎‡9 1‏
919 ‎‡a pathogenicityevaluationofbrca1andbrca2unclassifiedvariantsidentifiedinportuguesebreastovariancancerfamilies‏ ‎‡A Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families‏ ‎‡9 1‏
919 ‎‡a overexpressionofthemitoticcheckpointgenesbub1andbubr1isassociatedwithgenomiccomplexityinclearcellkidneycarcinomas‏ ‎‡A Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas.‏ ‎‡9 1‏
919 ‎‡a ovarianmetastasisfromuvealmelanomawithmlh1pms2proteinlossinapatientwithgermlinemlh1mutatedlynchsyndromeconsequenceorcoincidence‏ ‎‡A Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?‏ ‎‡9 1‏
919 ‎‡a oncogenicmechanismsofhoxb13missensemutationsinprostatecarcinogenesis‏ ‎‡A Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis.‏ ‎‡9 1‏
919 ‎‡a novel5fusionpartnersofetv1andetv4inprostatecancer‏ ‎‡A Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer‏ ‎‡9 1‏
919 ‎‡a nosignificantroleforbetatubulinmutationsandmismatchrepairdefectsinovariancancerresistancetopaclitaxelcisplatin‏ ‎‡A No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin‏ ‎‡9 1‏
919 ‎‡a negativemr40chronicmyeloidleukaemiaanditspossibleimplicationsfortreatmentfreeremission‏ ‎‡A Negative MR4·0 chronic myeloid leukaemia and its possible implications for treatment-free remission‏ ‎‡9 1‏
919 ‎‡a ncoa2isacandidatetargetgeneof8qgainassociatedwithclinicallyaggressiveprostatecancer‏ ‎‡A NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.‏ ‎‡9 1‏
919 ‎‡a myeloiddiseasewiththecsf3rt618imutationaftercll‏ ‎‡A Myeloid Disease with the CSF3R T618I Mutation after CLL‏ ‎‡9 1‏
919 ‎‡a mutationsinexon14ofdihydropyrimidinedehydrogenaseand5fluorouraciltoxicityinportuguesecolorectalcancerpatients‏ ‎‡A Mutations in exon 14 of dihydropyrimidine dehydrogenase and 5-Fluorouracil toxicity in Portuguese colorectal cancer patients‏ ‎‡9 1‏
919 ‎‡a multiplenumericalchromosomeaberrationsincancerwhataretheircausesandwhataretheirconsequences‏ ‎‡A Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences?‏ ‎‡9 1‏
919 ‎‡a multimodalgeneticdiagnosisofsolidvariantalveolarrhabdomyosarcoma‏ ‎‡A Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma.‏ ‎‡9 1‏
919 ‎‡a mt1ghypermethylationisassociatedwithhighertumorstageinprostatecancer‏ ‎‡A MT1G hypermethylation is associated with higher tumor stage in prostate cancer‏ ‎‡9 1‏
919 ‎‡a msh6germlinemutationsinearlyonsetcolorectalcancerpatientswithoutfamilyhistoryofthedisease‏ ‎‡A MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease‏ ‎‡9 1‏
919 ‎‡a molecularsubtypingofprimaryprostatecancerrevealsspecificandsharedtargetgenesofdifferentetsrearrangements‏ ‎‡A Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements‏ ‎‡9 1‏
919 ‎‡a moleculardiagnosisoftheportuguesefoundermutationbrca2100156157insalu‏ ‎‡A Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu.‏ ‎‡9 1‏
919 ‎‡a molecularcytogeneticcharacterizationofproximaltypeepithelioidsarcoma‏ ‎‡A Molecular cytogenetic characterization of proximal-type epithelioid sarcoma‏ ‎‡9 1‏
919 ‎‡a molecularcircuitinvolvingklk4integratesandrogenandmtorsignalinginprostatecancer‏ ‎‡A Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.‏ ‎‡9 1‏
919 ‎‡a molecularcharacterizationofthemllsept6fusiongeneinacutemyeloidleukemiaidentificationofnovelfusiontranscriptsandcloningofgenomicbreakpointjunctions‏ ‎‡A Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions‏ ‎‡9 1‏
919 ‎‡a molecularcharacterizationofararemllaf4mllaff1fusionrearrangementininfantleukemia‏ ‎‡A Molecular characterization of a rare MLL–AF4 (MLL–AFF1) fusion rearrangement in infant leukemia‏ ‎‡9 1‏
919 ‎‡a molecularcharacterizationofararemllaf4‏ ‎‡A Molecular characterization of a rare MLL–AF4‏ ‎‡9 1‏
919 ‎‡a mllseptingenefusionsinhematologicalmalignancies‏ ‎‡A MLL-SEPTIN gene fusions in hematological malignancies‏ ‎‡9 1‏
919 ‎‡a mitochondrialgenomealterationsinrectalandsigmoidcarcinomas‏ ‎‡A Mitochondrial genome alterations in rectal and sigmoid carcinomas‏ ‎‡9 1‏
919 ‎‡a mitochondrialdnacontrolregionsequencevariationintheneportuguesejewishcommunity‏ ‎‡A Mitochondrial DNA-control region sequence variation in the NE Portuguese Jewish community‏ ‎‡9 1‏
919 ‎‡a 51fraumenilikesyndromeassociatedwithalargebrca1intragenicdeletion‏ ‎‡A Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion‏ ‎‡9 1‏
919 ‎‡a lapatinibcapecitabineversuscapecitabinealoneasradiosensitizersinraswildtyperesectablerectalcanceranadaptiverandomizedphase2triallarrctrialstudyprotocolforarandomizedcontrolledtrial‏ ‎‡A Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trial‏ ‎‡9 1‏
919 ‎‡a karyotypicfindingsintumorsofthevulvaandvagina‏ ‎‡A Karyotypic Findings in Tumors of the Vulva and Vagina‏ ‎‡9 1‏
919 ‎‡a karyotypicevolutioninbreastcarcinomaswith11q10andder116q10p10astheprimarychromosomeabnormality‏ ‎‡A Karyotypic Evolution in Breast Carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the Primary Chromosome Abnormality‏ ‎‡9 1‏
919 ‎‡a karyotypicevolutioninbreastcarcinomaswith1‏ ‎‡A Karyotypic Evolution in Breast Carcinomas with i‏ ‎‡9 1‏
919 ‎‡a karyotypicdivergenceandconvergencein2synchronouslungmetastasesofaclearcellsarcomaoftendonsandaponeuroseswitht1222q13q12andtype1ewsatf1‏ ‎‡A Karyotypic divergence and convergence in two synchronous lung metastases of a clear cell sarcoma of tendons and aponeuroses with t(12;22)(q13;q12) and type 1 EWS/ATF1.‏ ‎‡9 1‏
919 ‎‡a karyotypicdivergenceandconvergencein2synchronouslungmetastasesofaclearcellsarcomaoftendonsandaponeuroseswitht‏ ‎‡A Karyotypic divergence and convergence in two synchronous lung metastases of a clear cell sarcoma of tendons and aponeuroses with t‏ ‎‡9 1‏
919 ‎‡a karyotypiccomparisonsofmultipletumorousandmacroscopicallynormalsurroundingtissuesamplesfrompatientswithbreastcancer‏ ‎‡A Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer‏ ‎‡9 1‏
919 ‎‡a karyotypicchangesinphyllodestumorsofthebreast‏ ‎‡A Karyotypic changes in phyllodes tumors of the breast‏ ‎‡9 1‏
919 ‎‡a investigatingthepossiblecausalroleofcoffeeconsumptionwithprostatecancerriskandprogressionusingmendelianrandomizationanalysis‏ ‎‡A Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis‏ ‎‡9 1‏
919 ‎‡a intratumorgenomicheterogeneityinbreastcancerwithclonaldivergencebetweenprimarycarcinomasandlymphnodemetastases‏ ‎‡A Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases‏ ‎‡9 1‏
919 ‎‡a intraepidermalepidermotropicmetastaticmelanomaaclinicalandhistopathologicalmimickerofmelanomainsituoccurringinmultiplicity‏ ‎‡A Intraepidermal epidermotropic metastatic melanoma: a clinical and histopathological mimicker of melanoma in situ occurring in multiplicity‏ ‎‡9 1‏
919 ‎‡a internationaldistributionandageestimationoftheportuguesebrca2100156157insalufoundermutation‏ ‎‡A International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.‏ ‎‡9 1‏
919 ‎‡a implementationofnextgenerationsequencingformoleculardiagnosisofhereditarybreastandovariancancerhighlightsitsgeneticheterogeneity‏ ‎‡A Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity‏ ‎‡9 1‏
919 ‎‡a immunohistochemicalmolecularphenotypesofgastriccancerbasedonsox2andcdx2predictpatientoutcome‏ ‎‡A Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome‏ ‎‡9 1‏
919 ‎‡a identificationof2novelhoxb13germlinemutationsinportugueseprostatecancerpatients‏ ‎‡A Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients‏ ‎‡9 1‏
919 ‎‡a identificationofsomatictertpromotermutationsinfamilialnonmedullarythyroidcarcinomas‏ ‎‡A Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas‏ ‎‡9 1‏
919 ‎‡a identificationofpreviouslyunrecognizedfapinchildrenwithgardnerfibroma‏ ‎‡A Identification of previously unrecognized FAP in children with Gardner fibroma‏ ‎‡9 1‏
919 ‎‡a hypermethylationofcyclind2isassociatedwithlossofmrnaexpressionandtumordevelopmentinprostatecancer‏ ‎‡A Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer‏ ‎‡9 1‏
919 ‎‡a hyperdiploidywith5866chromosomesinchildhoodbacutelymphoblasticleukemiaishighlycurable58951clgeortcresults‏ ‎‡A Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results.‏ ‎‡9 1‏
919 ‎‡a hybridoncocyticchromophoberenalcelltumoranintegratedgeneticandepigeneticcharacterizationofacase‏ ‎‡A Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case‏ ‎‡9 1‏
919 ‎‡a highlysensitivedetectionofthemgb1transcriptmammaglobinintheperipheralbloodofbreastcancerpatients‏ ‎‡A Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients‏ ‎‡9 1‏
919 ‎‡a highlysensitivedetectionofthemgb1transcript‏ ‎‡A Highly sensitive detection of the MGB1 transcript‏ ‎‡9 1‏
919 ‎‡a highresolutionmeltinganalysisofkrasbrafandpik3cainkrasexon2wildtypemetastaticcolorectalcancer‏ ‎‡A High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer‏ ‎‡9 1‏
919 ‎‡a highpromotermethylationlevelsofapcpredictpoorprognosisinsextantbiopsiesfromprostatecancerpatients‏ ‎‡A High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.‏ ‎‡9 1‏
919 ‎‡a heterogeneousgeneticprofilesinsofttissuemyoepitheliomas‏ ‎‡A Heterogeneous genetic profiles in soft tissue myoepitheliomas‏ ‎‡9 1‏
919 ‎‡a hereditarypredispositiontoprostatecancerfromgeneticstoclinicalimplications‏ ‎‡A Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications‏ ‎‡9 1‏
919 ‎‡a hereditarygastrointestinalstromaltumorssharingthekitexon17germlinemutationpasp820tyrdevelopthroughdifferentcytogeneticprogressionpathways‏ ‎‡A Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways‏ ‎‡9 1‏
919 ‎‡a haplotypeandquantitativetranscriptanalysesofportuguesebreastovariancancerfamilieswiththebrca1r71gfoundermutationofgalicianorigin‏ ‎‡A Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin‏ ‎‡9 1‏
919 ‎‡a germlinepathogenicvariantsinpalb2andothercancerpredisposinggenesinfamilieswithhereditarydiffusegastriccancerwithoutcdh1mutationawholeexomesequencingstudy‏ ‎‡A Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.‏ ‎‡9 1‏
919 ‎‡a germlinemutationsinpalb2brca1andrad51cwhichregulatednarecombinationrepairinpatientswithgastriccancer‏ ‎‡A Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer‏ ‎‡9 1‏
919 ‎‡a genotypicandphenotypicclassificationofcancerhowshouldtheimpactofthe2diagnosticapproachesbestbebalanced‏ ‎‡A Genotypic and phenotypic classification of cancer: How should the impact of the two diagnostic approaches best be balanced?‏ ‎‡9 1‏
919 ‎‡a genomiccharacterizationof2largealumediatedrearrangementsofthebrca1gene‏ ‎‡A Genomic characterization of two large Alu-mediated rearrangements of the BRCA1 gene‏ ‎‡9 1‏
919 ‎‡a genomicchangesinchromosomes1016and10inmalignantperipheralnervesheathtumorsidentifyahighriskpatientgroup‏ ‎‡A Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group‏ ‎‡9 1‏
919 ‎‡a genomicanalysisofprostatecarcinomaspecimensobtainedviaultrasoundguidedneedlebiopsymaybeofuseinpreoperativedecisionmaking‏ ‎‡A Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making‏ ‎‡9 1‏
919 ‎‡a genomicaberrationsincarcinomasoftheuterinecorpus‏ ‎‡A Genomic aberrations in carcinomas of the uterine corpus‏ ‎‡9 1‏
919 ‎‡a genomesignaturesofcoloncarcinomacelllines‏ ‎‡A Genome signatures of colon carcinoma cell lines‏ ‎‡9 1‏
919 ‎‡a genomeprofilingofbreastcancercellsselectedagainstinvitroshowscopynumberchanges‏ ‎‡A Genome profiling of breast cancer cells selected against in vitro shows copy number changes‏ ‎‡9 1‏
919 ‎‡a genomecharacteristicsofprimarycarcinomaslocalrecurrencescarcinomatosesandlivermetastasesfromcolorectalcancerpatients‏ ‎‡A Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients‏ ‎‡9 1‏
919 ‎‡a genetictestingandclinicalmanagementpracticesforvariantsinnonbrca12breastandbreastovariancancersusceptibilitygenesaninternationalsurveybytheevidencebasednetworkfortheinterpretationofgermlinemutantalleles Enigma 100‏ ‎‡A Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) C‏ ‎‡9 1‏
919 ‎‡a geneticprofilingofcolorectalcancerlivermetastasesbycombinedcomparativegenomichybridizationandgbandinganalysis‏ ‎‡A Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis.‏ ‎‡9 1‏
919 ‎‡a geneticdiagnosisofalveolarrhabdomyosarcomainthebonemarrowofapatientwithoutevidenceofprimarytumor‏ ‎‡A Genetic diagnosis of alveolar rhabdomyosarcoma in the bone marrow of a patient without evidence of primary tumor‏ ‎‡9 1‏
919 ‎‡a geneticcounsellingandtestingofsusceptibilitygenesfortherapeuticdecisionmakinginbreastcanceraneuropeanconsensusstatementandexpertrecommendations‏ ‎‡A Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations‏ ‎‡9 1‏
919 ‎‡a geneticbasisofpdl1overexpressionindiffuselargebcelllymphomas‏ ‎‡A Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas‏ ‎‡9 1‏
919 ‎‡a geneticandclinicalcharacterizationof45acuteleukemiapatientswithmllgenerearrangementsfromasingleinstitution‏ ‎‡A Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.‏ ‎‡9 1‏
919 ‎‡a genepaneltumortestinginovariancancerpatientssignificantlyincreasestheyieldofclinicallyactionablegermlinevariantsbeyondbrca1brca2‏ ‎‡A Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond BRCA1/BRCA2‏ ‎‡9 1‏
919 ‎‡a geneandpathwaylevelanalysesofgermlinednarepairgenevariantsandprostatecancersusceptibilityusingtheicogsgenotypingarray‏ ‎‡A Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array‏ ‎‡9 1‏
919 ‎‡a geneamplificationofthehistonemethyltransferasesetdb1contributestohumanlungtumorigenesis‏ ‎‡A Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis‏ ‎‡9 1‏
919 ‎‡a fullinframeexon3skippingofbrca2confershighriskofbreastandorovariancancer‏ ‎‡A Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.‏ ‎‡9 1‏
919 ‎‡a frequentcopynumbergainsat1q21and1q32areassociatedwithoverexpressionoftheetstranscriptionfactorsetv3andelf3inbreastcancerirrespectiveofmolecularsubtypes‏ ‎‡A Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes‏ ‎‡9 1‏
919 ‎‡a frequentalterationsincytoskeletonremodellinggenesinprimaryandmetastaticlungadenocarcinomas‏ ‎‡A Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas‏ ‎‡9 1‏
919 ‎‡a frequent1433sigmapromotermethylationinbenignandmalignantprostatelesions‏ ‎‡A Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions‏ ‎‡9 1‏
919 ‎‡a frequencyofnup98nsd1fusiontranscriptinchildhoodacutemyeloidleukaemia‏ ‎‡A Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia‏ ‎‡9 1‏
919 ‎‡a foxe1polymorphismsareassociatedwithfamilialandsporadicnonmedullarythyroidcancersusceptibility‏ ‎‡A FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility‏ ‎‡9 1‏
919 ‎‡a fluorescenceinsituhybridizationofoldgbandedandmountedchromosomepreparations‏ ‎‡A Fluorescence in situ hybridization of old G-banded and mounted chromosome preparations‏ ‎‡9 1‏
919 ‎‡a fli1isanoveletstranscriptionfactorinvolvedingenefusionsinprostatecancer‏ ‎‡A FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer‏ ‎‡9 1‏
919 ‎‡a feasibilityofdifferentialdiagnosisofkidneytumorsbycomparativegenomichybridizationoffineneedleaspirationbiopsies‏ ‎‡A Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies‏ ‎‡9 1‏
919 ‎‡a familialvssporadicpapillarythyroidcarcinomaamatchedcasecomparativestudyshowingsimilarclinicalprognosticbehaviour‏ ‎‡A Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour‏ ‎‡9 1‏
919 ‎‡a expressionpatternoftheseptingenefamilyinacutemyeloidleukemiaswithandwithoutmll7fusiongenes‏ ‎‡A Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.‏ ‎‡9 1‏
919 ‎‡a expressionchangesofthemadmitoticcheckpointgenefamilyinrenalcellcarcinomascharacterizedbynumericalchromosomechanges‏ ‎‡A Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changes‏ ‎‡9 1‏
919 ‎‡a exomesequencingrevealsnovelmutationtargetsindiffuselargebcelllymphomasderivedfromchinesepatients‏ ‎‡A Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.‏ ‎‡9 1‏
919 ‎‡a evaluationofbreastcancerpolyclonalitybycombinedchromosomebandingandcomparativegenomichybridizationanalysis‏ ‎‡A Evaluation of breast cancer polyclonality by combined chromosome banding and comparative genomic hybridization analysis‏ ‎‡9 1‏
919 ‎‡a epigeneticregulationofwntsignalingpathwayinurologicalcancer‏ ‎‡A Epigenetic regulation of Wnt signaling pathway in urological cancer‏ ‎‡9 1‏
919 ‎‡a epigeneticregulationofefemp1inprostatecancerbiologicalrelevanceandclinicalpotential‏ ‎‡A Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential‏ ‎‡9 1‏
919 ‎‡a epigeneticheterogeneityofhighgradeprostaticintraepithelialneoplasiacluesforclonalprogressioninprostatecarcinogenesis‏ ‎‡A Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.‏ ‎‡9 1‏
919 ‎‡a endometrialendometrioidadenocarcinomaassociatedwithprimitiveneuroectodermaltumouroftheuterusapoorprognosticsubtypeofuterinetumours‏ ‎‡A Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours‏ ‎‡9 1‏
919 ‎‡a egfrexonmutationdistributionandoutcomeinnonsmallcelllungcanceraportugueseretrospectivestudy‏ ‎‡A EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study‏ ‎‡9 1‏
919 ‎‡a dnarepairgenesareselectivelymutatedindiffuselargebcelllymphomas‏ ‎‡A DNA repair genes are selectively mutated in diffuse large B cell lymphomas‏ ‎‡9 1‏
919 ‎‡a distinctpatternsofkrasmutationsincolorectalcarcinomasaccordingtogermlinemismatchrepairdefectsandhmlh1methylationstatus‏ ‎‡A Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status‏ ‎‡9 1‏
919 ‎‡a distincthighresolutiongenomeprofilesofearlyonsetandlateonsetcolorectalcancerintegratedwithgeneexpressiondataidentifycandidatesusceptibilityloci‏ ‎‡A Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci‏ ‎‡9 1‏
919 ‎‡a discriminationbetweenmulticentricandmultifocalbreastcarcinomabycytogeneticinvestigationofmacroscopicallydistinctipsilaterallesions‏ ‎‡A Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions‏ ‎‡9 1‏
919 ‎‡a discontinuationoftyrosinekinaseinhibitorsin950patientsinrealworldclinicalpracticeatasingleinstitution‏ ‎‡A Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution‏ ‎‡9 1‏
919 ‎‡a detectionofgenepromoterhypermethylationinfineneedlewashingsfrombreastlesions‏ ‎‡A Detection of gene promoter hypermethylation in fine needle washings from breast lesions.‏ ‎‡9 1‏
919 ‎‡a detailedgenomewidescreeningforinterandintrachromosomalabnormalitiesbysequentialgbandingandrxfishcolorbandingofthesamemetaphasecells‏ ‎‡A Detailed genome-wide screening for inter- and intrachromosomal abnormalities by sequential G-banding and RxFISH color banding of the same metaphase cells‏ ‎‡9 1‏
919 ‎‡a detailedanalysisofexpressionandpromotermethylationstatusofapoptosisrelatedgenesinprostatecancer‏ ‎‡A Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer‏ ‎‡9 1‏
919 ‎‡a desmoplasticsmallroundcelltumordiagnosisbyfineneedleaspirationcytology‏ ‎‡A Desmoplastic small round cell tumor: diagnosis by fine-needle aspiration cytology‏ ‎‡9 1‏
919 ‎‡a deregulationofpax2expressioninrenalcelltumoursmechanismsandpotentialuseindifferentialdiagnosis‏ ‎‡A Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis‏ ‎‡9 1‏
919 ‎‡a cytogeneticpolyclonalityintumorsofthebreast‏ ‎‡A Cytogenetic polyclonality in tumors of the breast.‏ ‎‡9 1‏
919 ‎‡a cytogeneticcomparisonofprimarytumorsandlymphnodemetastasesinbreastcancerpatients‏ ‎‡A Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients‏ ‎‡9 1‏
919 ‎‡a 12qamplificationdefinesasubtypeofextraskeletalosteosarcomawithgoodprognosisthatisthesofttissuehomologueofparostealosteosarcoma‏ ‎‡A 12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma.‏ ‎‡9 1‏
919 ‎‡a 8qgainisanindependentpredictorofpoorsurvivalindiagnosticneedlebiopsiesfromprostatecancersuspects‏ ‎‡A 8q Gain Is an Independent Predictor of Poor Survival in Diagnostic Needle Biopsies from Prostate Cancer Suspects‏ ‎‡9 1‏
919 ‎‡a 8q24copynumbergainsandexpressionofthe100mycmrnastabilizingproteincrdbpinprimarybreastcarcinomas‏ ‎‡A 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas‏ ‎‡9 1‏
919 ‎‡a largescaleanalysisofgeneticvariantswithinputativemirnabindingsitesinprostatecancer‏ ‎‡A A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer‏ ‎‡9 1‏
919 ‎‡a novelexonicrearrangementaffectingmlh1andthecontiguouslrrfip2isafoundermutationinportugueselynchsyndromefamilies‏ ‎‡A A novel exonic rearrangement affecting MLH1 and the contiguous LRRFIP2 is a founder mutation in Portuguese Lynch syndrome families‏ ‎‡9 1‏
919 ‎‡a novelmllsept2fusionvariantintherapyrelatedmyelodysplasticsyndrome‏ ‎‡A A novel MLL-SEPT2 fusion variant in therapy-related myelodysplastic syndrome‏ ‎‡9 1‏
919 ‎‡a novelsplicedfusionofmllwithct45a2inapediatricbiphenotypicacuteleukemia‏ ‎‡A A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia.‏ ‎‡9 1‏
919 ‎‡a quantitativepromotermethylationprofileofprostatecancer‏ ‎‡A A quantitative promoter methylation profile of prostate cancer.‏ ‎‡9 1‏
919 ‎‡a cytogeneticcluestobreastcarcinogenesis‏ ‎‡A Cytogenetic clues to breast carcinogenesis‏ ‎‡9 1‏
919 ‎‡a universalassayfordetectionofoncogenicfusiontranscriptsbyoligomicroarrayanalysis‏ ‎‡A A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis‏ ‎‡9 1‏
919 ‎‡a aa9intsnpinteractionpatternsearchusingnonhierarchicaladditivemodelset‏ ‎‡A AA9int: SNP interaction pattern search using non-hierarchical additive model set‏ ‎‡9 1‏
919 ‎‡a aberrantcellularretinolbindingprotein1crbp1geneexpressionandpromotermethylationinprostatecancer‏ ‎‡A Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer‏ ‎‡9 1‏
919 ‎‡a acutemegakaryoblasticleukemiawitha4wayvarianttranslocationoriginatingtherbm15mkl1fusiongene‏ ‎‡A Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene‏ ‎‡9 1‏
919 ‎‡a acutemyeloidleukemiawithinv8p11q13‏ ‎‡A Acute myeloid leukemia with inv(8)(p11q13).‏ ‎‡9 1‏
919 ‎‡a adamts1crabp1andnr3c1identifiedasepigeneticallyderegulatedgenesincolorectaltumorigenesis‏ ‎‡A ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.‏ ‎‡9 1‏
919 ‎‡a adenomasandfollicularcarcinomasofthethyroiddisplay2majorpatternsofchromosomalchanges‏ ‎‡A Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes‏ ‎‡9 1‏
919 ‎‡a afterangelinaandthesupremecourtdecisionwheredowe5fromherebrcagenetestinginrhodeislandsportuguesepopulation‏ ‎‡A After Angelina and the Supreme Court Decision, where do we go from here? BRCA gene testing in Rhode Island's Portuguese population.‏ ‎‡9 1‏
919 ‎‡a alcoholconsumptionandprostatecancerincidenceandprogressionamendelianrandomisationstudy‏ ‎‡A Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study‏ ‎‡9 1‏
919 ‎‡a alteredexpressionofkeycellcycleregulatorsinrenalcellcarcinomaassociatedwithxp112translocation‏ ‎‡A Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation‏ ‎‡9 1‏
919 ‎‡a alteredexpressionofmgmtinhighgradegliomasresultsfromthecombinedeffectofepigeneticandgeneticaberrations‏ ‎‡A Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations‏ ‎‡9 1‏
919 ‎‡a cytogeneticcharacterizationoftumorsofthevulvaandvagina‏ ‎‡A Cytogenetic characterization of tumors of the vulva and vagina‏ ‎‡9 1‏
919 ‎‡a cytogeneticandmoleculargeneticanalysesofendometrialstromalsarcomanonrandominvolvementofchromosomearms6pand7pandconfirmationofjazf1jjaz1genefusionint717‏ ‎‡A Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17)‏ ‎‡9 1‏
919 ‎‡a cytogeneticandmoleculargeneticanalysesofendometrialstromalsarcomanonrandominvolvementofchromosomearms6pand7pandconfirmationofjazf1jjaz1genefusionint‏ ‎‡A Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t‏ ‎‡9 1‏
919 ‎‡a cytogeneticanalysisoftumorclonality‏ ‎‡A Cytogenetic analysis of tumor clonality‏ ‎‡9 1‏
919 ‎‡a cytogeneticanalysisofseveralpseudomyxomaperitoneilesionsoriginatingfromamucinouscystadenomaoftheappendix‏ ‎‡A Cytogenetic analysis of several pseudomyxoma peritonei lesions originating from a mucinous cystadenoma of the appendix‏ ‎‡9 1‏
919 ‎‡a cytogeneticanalysisofmultifocalbreastcarcinomasdetectionofkaryotypicallyunrelatedclonesaswellasclonalsimilaritiesbetweentumourfoci‏ ‎‡A Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci.‏ ‎‡9 1‏
919 ‎‡a cytogeneticabnormalitiesinaninsituductalcarcinomaand5prophylacticallyremovedbreastsfrommembersofafamilywithhereditarybreastcancer‏ ‎‡A Cytogenetic abnormalities in anin situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer‏ ‎‡9 1‏
919 ‎‡a cysteinerichsecretoryprotein3crisp3isstronglyupregulatedinprostatecarcinomaswiththetmprss2ergfusiongene‏ ‎‡A Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene‏ ‎‡9 1‏
919 ‎‡a analysisoffoundermutationsinraretumorsassociatedwithhereditarybreastovariancancerrevealsanovelassociationofbrca2mutationswithampullaofvatercarcinomas‏ ‎‡A Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas‏ ‎‡9 1‏
919 ‎‡a cyclind1a870gpolymorphismandamplificationinlaryngealsquamouscellcarcinomaimplicationsoftumorlocalizationandtobaccoexposure‏ ‎‡A Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.‏ ‎‡9 1‏
919 ‎‡a csf1rcopynumberchangespointmutationsandrnaandproteinoverexpressioninrenalcellcarcinomas‏ ‎‡A CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas‏ ‎‡9 1‏
919 ‎‡a crypticchromosomerearrangementresultinginsytssx2fusiongeneinamonophasicsynovialsarcoma‏ ‎‡A Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma‏ ‎‡9 1‏
919 ‎‡a aresomebreastcarcinomaspolyclonalinorigin‏ ‎‡A Are some breast carcinomas polyclonal in origin?‏ ‎‡9 1‏
919 ‎‡a arraycghandgeneexpressionprofilingrevealsdistinctgenomicinstabilitypatternsassociatedwithdnarepairandcellcyclecheckpointpathwaysinewingssarcoma‏ ‎‡A Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma.‏ ‎‡9 1‏
919 ‎‡a assessingtheroleofinsulinlikegrowthfactorsandbindingproteinsinprostatecancerusingmendelianrandomizationgeneticvariantsasinstrumentsforcirculatinglevels‏ ‎‡A Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels‏ ‎‡9 1‏
919 ‎‡a assessmentofclonalrelationshipsinipsilateralandbilateralmultiplebreastcarcinomasbycomparativegenomichybridisationandhierarchicalclusteringanalysis‏ ‎‡A Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis‏ ‎‡9 1‏
919 ‎‡a assessmentoffusiongenestatusinsarcomasusingacustommadefusiongenemicroarray‏ ‎‡A Assessment of fusion gene status in sarcomas using a custom made fusion gene microarray‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2013‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 DNB|1074953916‏
996 ‎‡2 SUDOC|059805153‏
996 ‎‡2 ISNI|0000000068708401‏
996 ‎‡2 ISNI|0000000068405048‏
996 ‎‡2 BLBNB|000266994‏
996 ‎‡2 ISNI|0000000070522227‏
996 ‎‡2 PTBNP|237849‏
996 ‎‡2 BLBNB|000404985‏
996 ‎‡2 DNB|1014357306‏
996 ‎‡2 LC|n 82140144‏
996 ‎‡2 ISNI|0000000070709585‏
996 ‎‡2 ISNI|0000000069919454‏
996 ‎‡2 JPG|500016301‏
996 ‎‡2 RERO|A021519770‏
996 ‎‡2 NSK|000251439‏
996 ‎‡2 PTBNP|125560‏
996 ‎‡2 PTBNP|34710‏
996 ‎‡2 ISNI|0000000111538437‏
996 ‎‡2 ISNI|0000000039921852‏
996 ‎‡2 LC|n 2006211708‏
996 ‎‡2 NUKAT|n 2003065075‏
996 ‎‡2 NTA|353733385‏
996 ‎‡2 DNB|170958523‏
996 ‎‡2 SUDOC|166571016‏
996 ‎‡2 CAOONL|ncf11167866‏
996 ‎‡2 ISNI|0000000068712793‏
996 ‎‡2 PTBNP|1474360‏
996 ‎‡2 NTA|123934559‏
996 ‎‡2 PTBNP|1874432‏
996 ‎‡2 ISNI|000000041955840X‏
996 ‎‡2 LC|n 97034501‏
996 ‎‡2 PTBNP|1815937‏
996 ‎‡2 ISNI|0000000068818037‏
996 ‎‡2 BNF|15117802‏
996 ‎‡2 PTBNP|202778‏
996 ‎‡2 SUDOC|028505719‏
996 ‎‡2 ISNI|0000000428334109‏
996 ‎‡2 PTBNP|243150‏
996 ‎‡2 BAV|495_258184‏
996 ‎‡2 ISNI|0000000078923682‏
996 ‎‡2 RERO|A013537476‏
996 ‎‡2 ISNI|000000006821089X‏
996 ‎‡2 ISNI|0000000069494214‏
996 ‎‡2 PTBNP|262830‏
996 ‎‡2 PTBNP|256424‏
996 ‎‡2 PTBNP|1218186‏
996 ‎‡2 PTBNP|1231178‏
996 ‎‡2 PTBNP|192393‏
996 ‎‡2 PTBNP|197410‏
996 ‎‡2 LC|n 82003849‏
996 ‎‡2 PTBNP|1632704‏
996 ‎‡2 PTBNP|46590‏
996 ‎‡2 ISNI|0000000032523579‏
996 ‎‡2 LC|n 2024253784‏
996 ‎‡2 ISNI|0000000070420212‏
996 ‎‡2 ISNI|0000000068406059‏
996 ‎‡2 ISNI|0000000069417884‏
996 ‎‡2 LC|n 85051945‏
996 ‎‡2 PTBNP|216365‏
996 ‎‡2 BLBNB|000367164‏
996 ‎‡2 PTBNP|56151‏
996 ‎‡2 PTBNP|1108400‏
996 ‎‡2 ISNI|0000000068900903‏
996 ‎‡2 PTBNP|197787‏
996 ‎‡2 DNB|1057492620‏
996 ‎‡2 PLWABN|9813138556905606‏
996 ‎‡2 PTBNP|1544282‏
996 ‎‡2 BIBSYS|10008635‏
996 ‎‡2 PTBNP|144223‏
996 ‎‡2 NKC|jo2016911267‏
996 ‎‡2 ISNI|0000000070909122‏
996 ‎‡2 ISNI|0000000068600847‏
996 ‎‡2 PTBNP|1039115‏
996 ‎‡2 PTBNP|281741‏
996 ‎‡2 NTA|068948344‏
996 ‎‡2 PTBNP|77285‏
996 ‎‡2 PTBNP|1432913‏
996 ‎‡2 LC|no2021028368‏
996 ‎‡2 LC|n 2003044929‏
996 ‎‡2 DNB|118935976‏
996 ‎‡2 BIBSYS|90970265‏
996 ‎‡2 PTBNP|987504‏
996 ‎‡2 ISNI|0000000070123605‏
996 ‎‡2 BLBNB|000169358‏
996 ‎‡2 BLBNB|000496564‏
996 ‎‡2 RERO|A003891411‏
996 ‎‡2 PTBNP|247666‏
996 ‎‡2 BNF|12032833‏
996 ‎‡2 PTBNP|235479‏
996 ‎‡2 PLWABN|9810650186005606‏
996 ‎‡2 CAOONL|ncf11636437‏
996 ‎‡2 DNB|1141246902‏
996 ‎‡2 NDL|001190620‏
996 ‎‡2 PTBNP|1496798‏
996 ‎‡2 PTBNP|48974‏
996 ‎‡2 DNB|1053164823‏
996 ‎‡2 ISNI|0000000069824164‏
996 ‎‡2 ISNI|0000000068383897‏
996 ‎‡2 RERO|A008764799‏
996 ‎‡2 ISNI|0000000067971814‏
996 ‎‡2 ISNI|0000000116273343‏
996 ‎‡2 PTBNP|224956‏
996 ‎‡2 ISNI|000000007143881X‏
996 ‎‡2 PTBNP|111001‏
996 ‎‡2 BNE|XX990041‏
996 ‎‡2 NUKAT|n 2007094462‏
996 ‎‡2 BNF|15032830‏
996 ‎‡2 NKC|jo2016915957‏
996 ‎‡2 ISNI|0000000023484862‏
996 ‎‡2 BLBNB|000536738‏
996 ‎‡2 J9U|987007273746105171‏
996 ‎‡2 BLBNB|000560073‏
996 ‎‡2 ISNI|0000000069517092‏
996 ‎‡2 BLBNB|000511217‏
996 ‎‡2 PTBNP|172896‏
996 ‎‡2 BLBNB|000546304‏
996 ‎‡2 PTBNP|172609‏
996 ‎‡2 PTBNP|1560693‏
996 ‎‡2 ISNI|0000000070317469‏
996 ‎‡2 ISNI|0000000106542466‏
996 ‎‡2 PTBNP|1201448‏
996 ‎‡2 ISNI|0000000067686730‏
996 ‎‡2 PTBNP|246619‏
996 ‎‡2 PTBNP|799913‏
996 ‎‡2 ISNI|0000000108847079‏
996 ‎‡2 ISNI|0000000070397702‏
996 ‎‡2 ISNI|0000000069111770‏
996 ‎‡2 ISNI|0000000070406218‏
996 ‎‡2 PTBNP|185011‏
996 ‎‡2 NYNYRILM|362055‏
996 ‎‡2 PTBNP|286932‏
996 ‎‡2 PTBNP|1852692‏
996 ‎‡2 ISNI|0000000067418322‏
996 ‎‡2 PTBNP|1425268‏
996 ‎‡2 ISNI|0000000111862026‏
996 ‎‡2 LC|no2002057463‏
996 ‎‡2 PTBNP|1339383‏
996 ‎‡2 SUDOC|191693138‏
996 ‎‡2 PTBNP|1284848‏
996 ‎‡2 LC|n 97039542‏
996 ‎‡2 PTBNP|1644453‏
996 ‎‡2 ISNI|0000000068823629‏
996 ‎‡2 PTBNP|1429830‏
996 ‎‡2 ISNI|0000000069019333‏
996 ‎‡2 ISNI|0000000068085910‏
996 ‎‡2 ISNI|000000040007590X‏
996 ‎‡2 NII|DA17817944‏
996 ‎‡2 NII|DA07872833‏
996 ‎‡2 ISNI|000000011420853X‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Teixeira, Manuel António Rodrigues‏ ‎‡2 ISNI|0000000070406218‏ ‎‡3 viafid‏
998 ‎‡a Teixeira,‏ ‎‡b Manuel António Rodrigues‏ ‎‡2 PTBNP|1245310‏ ‎‡3 viafid‏ ‎‡3 title: (0.87, 'oncogenicgrproverexpressioninprostatecarcinomasharboringetsrearrangementsunicoveringdownstreamtargetsandtherapeuticpotential', 'uncoveringpotentialdownstreamtargetsofoncogenicgrproverexpressioninprostatecarcinomasharboringetsrearrangements')‏